Overview

Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery

Status:
NOT_YET_RECRUITING

Trial end date:
2026-08-30

Target enrollment:

Participant gender:

Summary

The investigators propose a multicenter randomized trial to test the renal safety of 6% hydroxyethyl starch (HES) 130/0.4 combined with sodium acetate Ringer's crystalloid solution in moderate-to-high cardiovascular risk patients having major abdominal surgery. The reference group will only be given sodium acetate Ringer's crystalloid.

Phase:

PHASE4

Details

Lead Sponsor:

Xiangya Hospital of Central South University

Treatments:

Hydroxyethyl Starch Derivatives